Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes.
Grace RF, Shimano KA, Bhat R, Neunert C, Bussel JB, Klaassen RJ, Lambert MP, Rothman JA, Breakey VR, Hege K, Bennett CM, Rose MJ, Haley KM, Buchanan GR, Geddis A, Lorenzana A, Jeng M, Pastore YD, Crary SE, Neier M, Neufeld EJ, Neu N, Forbes PW, Despotovic JM. Grace RF, et al. Among authors: haley km. Am J Hematol. 2019 Jul;94(7):741-750. doi: 10.1002/ajh.25479. Epub 2019 Apr 29. Am J Hematol. 2019. PMID: 30945320 Free PMC article. Clinical Trial.
Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study.
Neunert C, Despotovic J, Haley K, Lambert MP, Nottage K, Shimano K, Bennett C, Klaassen R, Stine K, Thompson A, Pastore Y, Brown T, Forbes PW, Grace RF; Pediatric ITP Consortium of North America (ICON). Neunert C, et al. Pediatr Blood Cancer. 2016 Aug;63(8):1407-13. doi: 10.1002/pbc.26003. Epub 2016 May 2. Pediatr Blood Cancer. 2016. PMID: 27135461 Free PMC article.
Physician decision making in selection of second-line treatments in immune thrombocytopenia in children.
Grace RF, Despotovic JM, Bennett CM, Bussel JB, Neier M, Neunert C, Crary SE, Pastore YD, Klaassen RJ, Rothman JA, Hege K, Breakey VR, Rose MJ, Shimano KA, Buchanan GR, Geddis A, Haley KM, Lorenzana A, Thompson A, Jeng M, Neufeld EJ, Brown T, Forbes PW, Lambert MP. Grace RF, et al. Among authors: haley km. Am J Hematol. 2018 Jul;93(7):882-888. doi: 10.1002/ajh.25110. Epub 2018 May 6. Am J Hematol. 2018. PMID: 29659042 Free PMC article.
Laboratory misdiagnosis of von Willebrand disease in post-menarchal females: A multi-center study.
Jaffray J, Staber JM, Malvar J, Sidonio R, Haley KM, Stillings A, Weyand A, Hege K, Jain S, Gupta S, Agnew C, Wheeler A, Pawar A, Sharma M, Chitlur M, OʼBrien SH, Kouides P. Jaffray J, et al. Among authors: haley km. Am J Hematol. 2020 Sep;95(9):1022-1029. doi: 10.1002/ajh.25869. Epub 2020 Jun 20. Am J Hematol. 2020. PMID: 32419248 Free article. Clinical Trial.
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.
Goldenberg NA, Kittelson JM, Abshire TC, Bonaca M, Casella JF, Dale RA, Halperin JL, Hamblin F, Kessler CM, Manco-Johnson MJ, Sidonio RF, Spyropoulos AC, Steg PG, Turpie AGG, Schulman S; Kids-DOTT Trial Investigators and the ATLAS Group. Goldenberg NA, et al. JAMA. 2022 Jan 11;327(2):129-137. doi: 10.1001/jama.2021.23182. JAMA. 2022. PMID: 35015038 Free PMC article. Clinical Trial.
Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years.
Goldenberg NA, Schulman S, Kittelson JM, Abshire TC, Casella JF, Dale R, Halperin JL, Hanson J, Kessler CM, Manco-Johnson MJ, McDevitt L, Sidonio RF, Spyropoulos AC, Steg PG, Bonaca MP; Multicenter Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) Trial Investigators and the Antithrombotic Trials Leadership and Steering (ATLAS) Group. Goldenberg NA, et al. J Thromb Haemost. 2024 Oct 24:S1538-7836(24)00631-7. doi: 10.1016/j.jtha.2024.09.038. Online ahead of print. J Thromb Haemost. 2024. PMID: 39461724
Platelet Disorders.
Haley KM. Haley KM. Pediatr Rev. 2020 May;41(5):224-235. doi: 10.1542/pir.2018-0359. Pediatr Rev. 2020. PMID: 32358028 Review.
Heavy menstrual bleeding clinics for adolescents.
Baldwin M, Haley KM, Staber JM. Baldwin M, et al. Among authors: haley km. Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):382-387. doi: 10.1182/hematology.2024000562. Hematology Am Soc Hematol Educ Program. 2024. PMID: 39644071 Free PMC article. Review.
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research to advance the health of people with inherited bleeding disorders with the potential to menstruate.
Baldwin MK, Ahmadzia HK, Bartlett DL, Bensen-Kennedy D, Desai V, Haley KM, Herman-Hilker SL, Kilgore AM, Kulkarni R, Lavin M, Luckey S, Matteson KA, Paulyson-Nuñez K, Philipp CS, Ragosta S, Rosen K, Rotellini D, Weyand AC. Baldwin MK, et al. Among authors: haley km. Expert Rev Hematol. 2023 Mar;16(sup1):71-86. doi: 10.1080/17474086.2023.2175660. Expert Rev Hematol. 2023. PMID: 36920864 Free PMC article.
34 results